Glycan Biosciences LLC
Records under this name other than patents Glycan Biosciences LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Glycan Biosciences LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,597,632 | Anionic oligosaccharide conjugates Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,346,845 | Anionic Conjugates of Glycosylated Bacterial Metabolite Formerly held In force · High confidence | In force | High confidence | |
| US 9,964,543 | Selection of medicaments that modulate the function and activity of interleukin 13 Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,903,958 | Therapeutic Agents and Methods of Producing Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,791,245 | Anionic Conjugates of Glycosylated Bacterial Metabolite Formerly held Lapsed on the fee record Ended Jul 29, 2026 · High confidence | Lapsed on the fee record | Ended Jul 29, 2026 | High confidence |
| US 8,209,131 | Therapeutic heparins and their binding to interleukins 4 and 5 and PECAM-1 Lapsed on the fee record Ended Jun 26, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 26, 2020 | USPTO record |